Quantitative Total Extensible Imaging (QTxI) vs ContaCT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Quantitative Total Extensible Imaging (QTxI)
by AIQ Solutions
VS
ContaCT
by Viz.AI

AI Verdict

Tool A (QTxI) specializes in quantitative analysis of medical images for detailed treatment monitoring, particularly in oncology, focusing on ROI quantification and change detection. Tool B (ContaCT) is an AI-powered care coordination platform that excels in rapid disease detection (e.g., stroke, PE) and streamlining clinical workflows through alerts and communication. While both leverage AI and medical imaging for clinical decision support, QTxI is geared towards in-depth analytical follow-up, whereas ContaCT prioritizes acute detection and care orchestration.

Choose Quantitative Total Extensible Imaging (QTxI) if…

Choose Quantitative Total Extensible Imaging (QTxI) if your primary need is advanced quantitative analysis and precise tracking of disease progression and treatment response, particularly in oncology. This tool excels at identifying, contouring, and statistically analyzing Regions of Interest on DICOM CT and PET images, providing detailed insights for long-term patient management and research.

View Quantitative Total Extensible Imaging (QTxI) →

Choose ContaCT if…

Choose ContaCT if your priority is accelerating the detection of acute conditions and streamlining care coordination across your hospital network. Its AI-powered alerts for time-sensitive diseases like stroke, coupled with real-time communication and mobile image viewing, are ideal for improving patient triage and ensuring rapid intervention.

View ContaCT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Quantitative Total Extensible Imaging (QTxI) ContaCT
Pricing Contact for pricing Subscription-based
Deployment Cloud-based Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR).
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ContaCT

Tool B emphasizes real-time alerts, a mobile application for specialists to view images and communicate, and secure group messaging. These features suggest a highly integrated and immediate user experience designed for rapid care coordination in fast-paced clinical environments.

Clinical Value

ContaCT

While Tool A offers deep quantitative analysis for oncology treatment monitoring, Tool B focuses on accelerating disease detection and streamlining workflows across multiple acute, time-sensitive conditions like stroke and pulmonary embolism. Its widespread adoption in over 1,700 hospitals globally and impact on time-to-treatment for critical conditions suggest a broader and more immediate clinical impact on patient outcomes.

Pricing & Value

Tie

Both tools lack transparent public pricing, requiring direct contact with the vendor for custom quotes. Without specific cost information or detailed ROI case studies, it is impossible to definitively compare their pricing and value propositions.

Enterprise Readiness

ContaCT

Both are cloud-based, HIPAA compliant, and FDA cleared. However, Tool B explicitly highlights integration with existing hospital IT infrastructure (PACS, EHR) and boasts adoption in over 1,700 hospitals globally, demonstrating a proven track record for large-scale enterprise deployment and seamless integration.

Innovation

ContaCT

Tool A innovates in deep quantitative imaging analysis for oncology. Tool B, however, is a 'pioneering AI-powered care coordination platform' that offers real-time AI-powered alerts, mobile-enabled workflows, and automated chart summarization across multiple acute conditions, representing a broader and more disruptive innovation in care delivery and workflow optimization.

Support & Docs

ContaCT

Viz.ai (Tool B) provides robust support, including 24/7/365 urgent phone support, email support, in-app support, a comprehensive knowledge base, and a dedicated customer success team with specialists and training resources. AIQ Solutions (Tool A) mentions a support site and technical engineers but lacks the detailed, multi-channel, and dedicated customer success offerings of Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Quantitative Total Extensible Imaging (QTxI) ContaCT
Name Quantitative Total Extensible Imaging (QTxI) ContaCT
Company AIQ Solutions Viz.AI
Tagline Optimizing late-stage cancer care with technology-enabled service. The leading AI care coordination platform for disease detection and workflow optimization.
Primary Focus Quantitative analysis of Regions of Interest for improved treatment monitoring, particularly in oncology. Accelerates disease detection and streamlines clinical workflows, particularly for stroke.
Key Modalities/Data Types DICOM CT and PET Not specified
Specialties Nuclear Medicine, Oncology, Radiology Emergency Medicine, Neurology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Quantitative Total Extensible Imaging (QTxI) and ContaCT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Quantitative Total Extensible Imaging (QTxI) by AIQ Solutions is primarily designed for quantitative analysis of digital medical images (DICOM CT and PET) to improve treatment monitoring, particularly in oncology and late-stage cancer care. ContaCT by Viz.AI is an AI-powered care coordination platform focused on accelerating disease detection and streamlining clinical workflows for acute conditions like stroke (LVO, ICH), hypertrophic cardiomyopathy (HCM), pulmonary embolism (PE), and aneurysm.
QTxI specializes in detailed quantitative and statistical analysis of Regions of Interest (ROIs) on CT and PET scans, including 3D interactive rendering and automated quantification of changes in ROIs for treatment response assessment. ContaCT, on the other hand, uses AI for rapid disease detection, generating real-time alerts and notifications to facilitate quicker clinical intervention and care coordination.
QTxI explicitly supports the evaluation and information management of digital medical images from DICOM CT and PET modalities. ContaCT's primary applications, such as stroke detection, typically involve CT imaging, and it is designed to analyze CT images of the brain.
QTxI offers cloud-based HIPAA-compliant data pipelines and automated report generation, focusing on providing detailed quantitative analysis reports. ContaCT is also cloud-based and integrates with existing hospital IT infrastructure like PACS and EHR systems, additionally featuring a mobile application for specialists to view images and communicate securely.
ContaCT provides real-time AI-powered alerts and notifications, along with secure, HIPAA-compliant group communication messaging via a mobile application to accelerate specialist involvement. QTxI focuses on quantitative analysis and automated report generation for treatment monitoring, and does not explicitly mention real-time alerting or communication features.
QTxI generates automated reports that include quantitative and statistical analysis of full or partial-body scans, 3D interactive rendering of images with highlighted ROIs, and quantified changes in ROIs over time. ContaCT offers AI-powered alerts, a high-fidelity 3D web and mobile image viewer, and automated chart summarization, along with guideline-based recommendations.

More Comparisons

eCARTv5 Clinical Deterioration Suite (“eCART”) vs Google Med-PaLM 2
ChatGPT vs Google Med-PaLM 2
When choosing between ChatGPT and Google Med-PaLM 2, physicians should consider their primary use case and desired level of medical…
Brainomix 360 e-CTA vs Google Med-PaLM 2
DeepXray vs Google Med-PaLM 2

More matchups featuring Quantitative Total Extensible Imaging (QTxI) or ContaCT

Backers

Who funded each tool's parent company.

ContaCT

AI Tool Finder
AI-powered search. Results may not be comprehensive.